Ethical Challenges in Stroke Research
- 1 August 1998
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 29 (8) , 1725-1729
- https://doi.org/10.1161/01.str.29.8.1725
Abstract
Background—Ethical issues are a critical consideration in the design and conduct of clinical research. Summary of Review—A number of completed trials of proposed stroke treatments raise classical e...Keywords
This publication has 43 references indexed in Scilit:
- POTENTIAL ROLE OF INTERVENTIONAL NEUROVASCULAR THERAPY FOR CEREBROVASCULAR DISEASEThe Neurologist, 1997
- Thrombolytic Therapy with Streptokinase in Acute Ischemic StrokeNew England Journal of Medicine, 1996
- Dose escalation safety and tolerance study of the N-methyl-d-aspartate antagonist dextromethorphan in neurosurgery patientsJournal of Neurosurgery, 1996
- The Effects of Lifarizine in Acute Cerebral Infarction: A Pilot Safety StudyCerebrovascular Diseases, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Safety, Tolerability and Pharmacokinetics of the N‐Methyl‐d‐Aspartate Antagonist Ro‐01–6794/706 in Patients with Acute Ischemic StrokeabAnnals of the New York Academy of Sciences, 1995
- Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischaemiaNeurobiology of Disease, 1995
- CGS‐19755, A competitive NMDA receptor antagonist, reduces calcium‐calmodulin binding and improves outcome after global cerebral ischemiaAnnals of Neurology, 1990
- Calcium Antagonist (PY 108-068) Treatment May Further Decrease Flow in Ischemic Areas in Acute StrokeJournal of Cerebral Blood Flow & Metabolism, 1986
- Antihypertensive effectiveness of intravenous labetalol in accelerated hypertension.Hypertension, 1983